Words by Cheyenne Eugene
GOLD looks back at some of the top news stories from the pharmaceutical industry over the last few months, ranging from recent drug approvals to exciting new initiatives and much more
12 April
Draft guidance puts Pfizer and Shionogi’s antibiotics in the UK’s new antimicrobial financing model
16 April
‘Our Africa by Merck Foundation’ TV programme launches to raise awareness of health issues on the continent
26 April
PatientView survey shows improved corporate reputation for pharma among patient groups
17 May
MHRA approves Roche’s Vabysmo eye injection as treatment option for two leading forms of sight loss
25 May
Pfizer launches not-for-profit equity initiative to provide medicines to 45 lower-income countries
28 May
FDA grants accelerated approval for Novartis’ Kymriah for adult patients with relapsed or refractory follicular lymphoma
30 May
NRG Therapeutics wins £2.68m award to develop new treatments for neurodegenerative disorders
31 May
Sandoz launches ‘Act4Biosimilars’ initiative to improve patient access in over 30 countries by 2030
01 June
Pascal Soriot, CEO, AstraZeneca, awarded knighthood for services to UK life sciences and leadership during COVID-19
02 June
Regeneron buys exclusive license rights to Sanofi’s cancer treatment Libtayo for $900m
03 June
BMS announces acquisition of leading precision oncology company Turning Point Therapeutics
06 June
FDA approves GSK’s Priorix for the prevention of measles, mumps and rubella in those 12 months and older
This article features in GOLD 22 – read the full issue here.